Who are Moviprep（1-day treatment）'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Miralax-Gatorade Prep, Polyethylene glycol + ascorbate.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/moviprep-1-day-treatment.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Moviprep（1-day treatment） — Competitive Intelligence Brief

Moviprep（1-day treatment） (Moviprep（1-day treatment）) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic laxative bowel preparation agent. Area: Gastroenterology.

phase 3 Osmotic laxative bowel preparation agent Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Moviprep（1-day treatment） (Moviprep（1-day treatment）) — Nihon Pharmaceutical Co., Ltd. Moviprep is an osmotic laxative bowel preparation that draws water into the colon to cleanse it before medical procedures.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Moviprep（1-day treatment） TARGET	Moviprep（1-day treatment）	Nihon Pharmaceutical Co., Ltd	phase 3	Osmotic laxative bowel preparation agent
Miralax-Gatorade Prep	Miralax-Gatorade Prep	VA Office of Research and Development	marketed	Osmotic laxative bowel preparation agent
Polyethylene glycol + ascorbate	Polyethylene glycol + ascorbate	Parc de Salut Mar	marketed	Osmotic laxative bowel preparation agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic laxative bowel preparation agent class)

Nihon Pharmaceutical Co., Ltd · 1 drug in this class
Parc de Salut Mar · 1 drug in this class
VA Office of Research and Development · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Moviprep（1-day treatment） — Competitive Intelligence Brief. https://druglandscape.com/ci/moviprep-1-day-treatment. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab